We are live on ! Find out more
PAS

Professional Advisory Services Portfolio holdings

AUM $837M
1-Year Est. Return 20.44%
This Fund
S&P 500
This Quarter Est. Return
+18.86%
1 Year Est. Return
+20.44%
3 Year Est. Return
+69.3%
5 Year Est. Return
+62.42%
10 Year Est. Return
+241.59%
AUM
$836M
AUM Growth
+$111M
Cap. Flow
+$5.17M
Cap. Flow %
0.62%
Top 10 Hldgs %
38.84%
Holding
96
New
16
Increased
30
Reduced
17
Closed
3
Avg Time Held
22.5 quarters
Top 10 Avg Time Held
7.7 quarters
Top 20 Avg Time Held
13.4 quarters

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$30.4M
2
APH icon
Amphenol
APH
+$26.1M
3
T icon
AT&T
T
+$14.6M
4
SYK icon
Stryker
SYK
+$6.23M
5
PEP icon
PepsiCo
PEP
+$4.24M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Financials 18.03%
3 Healthcare 14.87%
4 Consumer Discretionary 9.97%
5 Miscellaneous 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.24T
$40.2M 4.81%
113,672
-9,419
-8% -$3.37M
2013 Q2
52 quarters
MSFT icon
2
Microsoft
MSFT
$3.98T
$34.6M 4.14%
92,639
+1,134
+1% +$459K
2014 Q1
49 quarters
AMZN icon
3
Amazon
AMZN
$2.75T
$34.6M 4.13%
144,964
-8,710
-6% -$2.19M
2020 Q1
25 quarters
TMO icon
4
Thermo Fisher Scientific
TMO
$249B
$32.5M 3.89%
64,819
+5,804
+10% +$2.79M
2018 Q1
33 quarters
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.12T
$32.2M 3.86%
64,394
+2,813
+5% +$1.35M
2014 Q1
49 quarters
APH icon
6
Amphenol
APH
$205B
$31.9M 3.82%
+361,910
New +$26.1M
2026 Q2
0 quarters
AZN icon
7
AstraZeneca
AZN
$251B
$30.2M 3.62%
+161,624
New +$30.4M
2026 Q2
0 quarters
IJH icon
8
iShares Core S&P Mid-Cap ETF
IJH
$121B
$30M 3.59%
389,361
+4,701
+1% +$345K
2024 Q4
6 quarters
AMD icon
9
Advanced Micro Devices
AMD
$933B
$29.7M 3.55%
51,067
-59,305
-54% -$24.3M
2024 Q4
6 quarters
AAPL icon
10
Apple
AAPL
$5.03T
$28.7M 3.44%
99,215
+3,992
+4% +$1.14M
2017 Q3
35 quarters
EMXC icon
11
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.8B
$28.2M 3.37%
275,475
-131,948
-32% -$12.5M
2022 Q1
17 quarters
J icon
12
Jacobs Solutions
J
$16.4B
$26.9M 3.22%
213,566
+25,179
+13% +$3.1M
2025 Q3
3 quarters
ELV icon
13
Elevance Health
ELV
$91.9B
$26.6M 3.18%
68,657
-8,231
-11% -$3.05M
2020 Q1
25 quarters
PEP icon
14
PepsiCo
PEP
$175B
$26.4M 3.16%
194,772
+28,358
+17% +$4.24M
2013 Q2
52 quarters
SYK icon
15
Stryker
SYK
$108B
$26.3M 3.14%
83,421
+19,767
+31% +$6.23M
2013 Q2
52 quarters
BKNG icon
16
Booking.com
BKNG
$120B
$25.5M 3.06%
143,331
+706
+0.5% +$120K
2022 Q4
14 quarters
SYY icon
17
Sysco
SYY
$39.3B
$25M 2.99%
299,057
+47,783
+19% +$3.62M
2023 Q4
10 quarters
AJG icon
18
Arthur J. Gallagher & Co
AJG
$60.5B
$24.9M 2.98%
108,452
+11,371
+12% +$2.41M
2018 Q1
33 quarters
USB icon
19
US Bancorp
USB
$87.5B
$24.4M 2.92%
403,988
-15,507
-4% -$869K
2013 Q2
52 quarters
V icon
20
Visa
V
$739B
$24.3M 2.91%
70,879
+2,467
+4% +$792K
2024 Q3
7 quarters
GD icon
21
General Dynamics
GD
$90.4B
$23.7M 2.84%
67,028
+2,562
+4% +$878K
2020 Q2
24 quarters
SPGI icon
22
S&P Global
SPGI
$120B
$22.7M 2.72%
55,728
+5,228
+10% +$2.21M
2019 Q1
29 quarters
CARR icon
23
Carrier Global
CARR
$44.4B
$22.1M 2.65%
301,813
-6,111
-2% -$399K
2020 Q2
24 quarters
ADI icon
24
Analog Devices
ADI
$196B
$22M 2.63%
55,283
-11,340
-17% -$4.49M
2017 Q4
34 quarters
TJX icon
25
TJX Companies
TJX
$157B
$21.6M 2.59%
142,656
+3,830
+3% +$606K
2014 Q3
47 quarters

Similar funds

Professional Advisory Services's Q2 2026 Portfolio in Review

As of Q2 2026, Professional Advisory Services held 96 positions worth $836M, up 15% from $724M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Professional Advisory Services's Q2 2026 filing shows 16 new, 30 increased, 17 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 161,624 shares worth $30.2M. The largest sale was Advanced Micro Devices, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Professional Advisory Services's largest Q2 2026 buy was AstraZeneca: 161,624 shares worth $30.2M.
  • Professional Advisory Services added most to AT&T in Q2 2026, an estimated $14.6M increase.
  • Professional Advisory Services's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $24.3M.
  • Professional Advisory Services fully exited Accenture in Q2 2026, selling an estimated $16.5M.
  • Professional Advisory Services's ten largest holdings make up 39% of its $836M portfolio in Q2 2026.
  • Professional Advisory Services opened 16 new positions and closed 3 in Q2 2026.
  • Professional Advisory Services's portfolio value rose 15% quarter-over-quarter to $836M.

Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.